Acasti Pharma Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Bi

The weak performance of Amarin (NASDAQ:AMRN) has been a head scratcher. Back in December, the company announced a major approval from the U.S. Food and Drug Administration. There was also a strong fou

Tuesday's big stock charts feature three big winners in Monday's big rally — all of which have hopes for further upside ahead.

LAVAL, Québec, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, develo

With shares down more than 80%, is there opportunity with Acasti Pharma (NASDAQ:ACST) stock? Don't bet on it! Shares have been hammered since January due to poor Phase 3 results for its prospective hy

Amarin stock has declined by nearly a quarter so far in 2020 on little news. That lower valuation makes AMRN intriguing.

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 27) Global Cord Blood Corp (...

There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Atricure (ATRC), Medtronic (MDT) and Acasti Pharma (ACST)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Atricure ( ATRC – Research Report ), Medtronic ( MDT – Research Report ) and Acasti Pharma ( ACST �

Wells Fargo lowered PVH Corp (NYSE: PVH) price target from $115 to $110. PVH closed at $89.37 on Friday. Bernstein raised the price target for Tesla Inc (NASDAQ: TSLA) from $...